Massaro, Alessandro and Giardinelli, Vito O. M. and Cosoli, Gabriele and Magaletti, Nicola and Leogrande, Angelo (2022): The Prediction of Hypertension Risk.
Preview |
PDF
MPRA_paper_113242.pdf Download (2MB) | Preview |
Abstract
This article presents an estimation of the hypertension risk based on a dataset on 1007 individuals. The application of a Tobit Model shows that “Hypertension” is positively associated to “Age”, “BMI-Body Mass Index”, and “Heart Rate”. The data show that the element that has the greatest impact in determining inflation risk is “BMI-Body Mass Index”. An analysis was then carried out using the fuzzy c-Means algorithm optimized with the use of the Silhouette coefficient. The result shows that the optimal number of clusters is 9. A comparison was then made between eight different machine-learning algorithms for predicting the value of the Hypertension Risk. The best performing algorithm is the Gradient Boosted Trees Regression according to the analyzed dataset. The results show that there are 37 individuals who have a predicted hypertension value greater than 0.75, 35 individuals who have a predicted hypertension value between 0.5 and 0.75, while 227 individuals have a hypertension value between 0.0 and 0.5 units.
Item Type: | MPRA Paper |
---|---|
Original Title: | The Prediction of Hypertension Risk |
English Title: | The Prediction of Hypertension Risk |
Language: | English |
Keywords: | Predictions, Machine Learning Algorithms, Correlation Matrix, Tobit Model, Fuzzy c-Means Clustering. |
Subjects: | C - Mathematical and Quantitative Methods > C0 - General > C00 - General C - Mathematical and Quantitative Methods > C0 - General > C01 - Econometrics C - Mathematical and Quantitative Methods > C0 - General > C02 - Mathematical Methods C - Mathematical and Quantitative Methods > C5 - Econometric Modeling > C50 - General C - Mathematical and Quantitative Methods > C8 - Data Collection and Data Estimation Methodology ; Computer Programs > C80 - General |
Item ID: | 113242 |
Depositing User: | Dr Angelo Leogrande |
Date Deposited: | 31 May 2022 15:06 |
Last Modified: | 31 May 2022 15:06 |
References: | [1] B. Zhou, R. M. Carrillo-Larco, G. Danaei, L. M. Riley, C. J. Paciorek, G. A. Stevens and J. Breckenkamp, “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants,” The Lancet, vol. 398, no. 10304, pp. 957-980, 2021. [2] A. A. Yurekli, N. Bilir and M. J. Husain, “Projecting burden of hypertension and its management in Turkey, 2015-2030,” PloS one, vol. 9, no. e0221556, p. 14, 2019. [3] J. Gąsowski and K. Piotrowicz, “Breast cancer, age, and hypertension: a complex issue,” Hypertension, vol. 59, no. 2, pp. 186-188, 2012. [4] H. C. Kim and M. C. Cho, “Korea hypertension fact sheet 2018,” Clinical hypertension, vol. 24, no. 1, pp. 1-4, 2018. [5] S. F. Mohamed, M. K. Mutua, R. Wamai, F. Wekesah, T. Haregu, P. Juma and E. Ogola, “Prevalence, awareness, treatment and control of hypertension and their determinants: results from a national survey in Kenya,” BMC public health, vol. 18, no. 3, pp. 1-1, 2018. [6] J. Kitt, R. Fox, K. L. Tucker and R. J. McManus, “New approaches in hypertension management: a review of current and developing technologies and their potential impact on hypertension care,” Current hypertension reports, vol. 21, no. 6, pp. 1-8, 2019. [7] K. Suvila, J. A. Lima, S. Cheng and T. J. Niiranen, “Clinical correlates of early-onset hypertension,” in American journal of hypertension, 34, 9, 2021, pp. 915-918. [8] L. E. Britton, D. C. Berry and J. M. Hussey, “Comorbid hypertension and diabetes among US women of reproductive age: prevalence and disparities,” in Journal of Diabetes and its Complications, 32, 12, 2018, pp. 1148-1152. [9] A. A. Frame and R. D. Wainford, “Mechanisms of altered renal sodium handling in age-related hypertension,” American Journal of Physiology-Renal Physiology, vol. 315, no. 1, 2018. [10] Y. Ostchega, C. D. Fryar, T. Nwankwo and D. T. Nguyen, “Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018,” NCHS data brief, vol. 364, pp. 1-8, 2020. [11] G. H. Anderson, “Effect of age on hypertension: analysis of over 4,800 referred hypertensive patients,” Saudi Journal of Kidney Diseases and Transplantation, vol. 3, no. 286, p. 10, 1999. [12] J. G. Abell, M. Kivimäki, A. Dugravot, A. G. Tabak, A. Fayosse, M. Shipley and A. Singh-Manoux, “Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension,” European heart journal, vol. 39, no. 33, pp. 3119-3125, 2018. [13] K. Suvila, E. L. McCabe, A. Lehtonen, J. E. Ebinger, J. A. Lima, S. Cheng and T. J. Niiranen, “Early onset hypertension is associated with hypertensive end-organ damage already by midlife,” Hypertension, vol. 74, no. 2, pp. 305-312., 2019. [14] K. Suvila, J. A. Lima, Y. Yano, Z. S. Tan, S. Cheng and T. J. Niiranen, “Early-but not late-onset hypertension is related to midlife cognitive function,” Hypertension, vol. 77, no. 3, pp. 972-979, 2021. [15] C. V. Ananth, C. M. Duzyj, S. Yadava, M. Schwebel, A. T. Tita and K. S. Joseph, “Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010,” Hypertension, vol. 74, no. 5, pp. 1089-1095, 2019. [16] F. Wallentin, B. Wettermark and T. Kahan, “ Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidit,” The Journal of Clinical Hypertension, vol. 20, no. 1, pp. 106-114, 2018. [17] C. M. Samanic, K. E. Barbour, Y. Liu, J. Fang, H. Lu, L. Schieb and K. J. Greenlund, “Prevalence of self-reported hypertension and antihypertensive medication use among adults—United States, 2017,” Morbidity and Mortality Weekly Report, vol. 69, no. 14, 2020. [18] S. E. Kjeldsen, “Hypertension and cardiovascular risk: General aspects,” Pharmacological research, vol. 129, pp. 95-99, 2018. [19] T. L. Strassburger, H. C. Lee, E. M. Daly, J. Szczepanik, J. S. Krasuski, M. J. Mentis and G. E. Alexander, “Interactive effects of age and hypertension on volumes of brain structures,” Stroke, vol. 28, no. 7, pp. 1410-1417, 1997. [20] Y. Someya, Y. Tamura, Y. Kohmura, K. Aoki, S. Kawai and H. Daida, “Slightly increased BMI at young age is a risk factor for future hypertension in Japanese men,” PloS one, vol. 1, no. e0191170, p. 13, 2018. [21] M. Coylewright, J. F. Reckelhoff and P. Ouyang, “Menopause and hypertension: an age-old debate,” Hypertension, vol. 51, no. 4, pp. 952-959, 2008. [22] A. Shukuri, T. Tewelde and T. Shaweno, “Prevalence of old age hypertension and associated factors among older adults in rural Ethiopia,” Integrated Blood Pressure Control, vol. 12, p. 23, 2019. [23] D. Min and E. Cho, “Associations among health behaviors, body mass index, hypertension, and diabetes mellitus: A path analysis,” Medicine, vol. 22, p. 97, 2018. [24] A. Jayedi, A. Rashidy‐Pour, M. Khorshidi and S. Shab‐Bidar, “Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose–response meta‐analysis of more than 2.3 million participants,” Obesity reviews, vol. 19, no. 5, pp. 654-667, 2018. [25] K. M. Alisherovna and Y. S. Tatlibayevich, “ASSESSMENT OF RISK FACTORS FOR ARTERIAL HYPERTENSION HYPERTENSION IN PREGNANT WOMEN,” CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, vol. 2, no. 3, pp. 214-217, 2021. [26] N. Li, T. Yang, W. Q. Yu and H. Liu, “Is waist-to-height ratio superior to body mass index and waist circumference in predicting the incidence of hypertension?,” Annals of Nutrition and Metabolism, vol. 74, no. 3, pp. 215-223, 2019. [27] H. H. Alhawari, S. Al-Shelleh, H. H. Alhawari, A. Al-Saudi, D. Aljbour Al-Majali, L. Al-Faris and S. A. AlRyalat, “Blood pressure and its association with gender, body mass index, smoking, and family history among university students,” nternational journal of hypertension, 2018. [28] H. Teng, J. Hu, G. W. Q. Dai, J. X. C. Liu and X. Zhu, “Body mass index trajectories during 6–18 years old and the risk of hypertension in young adult: a longitudinal study in Chinese population,” International journal of hypertension, 2021. [29] W. L. Cheah, C. T. Chang, H. Hazmi and G. W. F. Kho, “Using anthropometric indicator to identify hypertension in adolescents: a study in Sarawak, Malaysia,” International Journal of Hypertension, 2018. [30] E. Rajkumar and J. Romate, “Behavioural risk factors, hypertension knowledge, and hypertension in rural India,” International journal of hypertension, 2020. [31] C. Yu, H. Zhao, L. Pan, J. Zhang, X. Wang, L. Chang and G. Shan, “The additive interaction between body mass index and hypertension family history in han and yugur: the China National Health Survey (CNHS),” International Journal of Hypertension, 2019. [32] N. Sakolchai, P. Thawornchaisit, F. de Looze, C. M. Reid, S. A. Seubsman and A. Sleigh, “Defining risk thresholds: Appropriate body mass index cut-off for hypertension in Thai Cohort Study,” Interdisciplinary Research Review, vol. 14, no. 4, pp. 25-33, 2019. [33] Y. Nurdiantami, K. Watanabe, E. Tanaka, J. Pradono and T. Anme, “Association of general and central obesity with hypertension,” Clinical nutrition, vol. 37, no. 4, pp. 1259-1263, 2018. [34] G. G. Sagaro, M. Di Canio and F. Amenta, “Correlation between body mass index and blood pressure in seafarers,” Clinical and Experimental Hypertension, vol. 43, no. 2, pp. 189-195, 2021. [35] R. Indriawati and S. Syaifudin, “Relationship between Demographic Factors and Body Mass Index with the Prevention of Hypertension in Adolescents,” Journal of Health Promotion and Behavior, vol. 5, no. 2, pp. 72-78, 2020. [36] X. Niu, J. Chen, J. Wang, J. Li, D. Zeng, S. Wang and X. Hong, “Association between the uric acid and hypertension in community-based Chinese population: stratified analysis based on body mass index and age,” Journal of Thrombosis and Thromboly, 2021. [37] M. Van Hemelrijck, H. Ulmer, G. Nagel, R. S. Peter, J. Fritz, R. Myte and T. Stocks, “Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria,” PLoS One, vol. 6, no. e019, p. 13, 2018. [38] S. C. Larsson, M. Bäck, J. M. Rees, A. M. Mason and S. Burgess, “Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study,” European heart journal, vol. 41, no. 2, pp. 221-226, 2020. [39] S. G. Chrysant and G. S. Chrysant, “The single use of body mass index for the obesity paradox is misleading and should be used in conjunction with other obesity indices,” Postgraduate Medicine, vol. 131, no. 2, pp. 96-102, 2019. [40] L. A. Millard, N. M. Davies, K. Tilling, T. R. Gaunt and G. Davey Smith, “Searching for the causal effects of body mass index in over 300 000 participants in UK Biobank, using Mendelian randomization,” PLoS genetics, vol. 2, no. e1007951, p. 15, 2019. [41] A. Ajah, F. Amah-Taria and I. Iwu, “Relationship between Body Mass Index and Hypertension among Police Officers in Port Harcourt,” J Cardiovasc Disord, vol. 1, no. 1039, p. 5, 2018. [42] D. D. Zhang, X. J. Liu, B. Y. Wang, Y. C. Ren, Y. Zhao, F. Y. Liu and D. S. Hu, “Age-related modification effect on the association between body mass index and the risk of hypertension: A Cohort Study on Chinese people living in the rural areas,” Zhonghua liu Xing Bing xue za zhi= Zhonghua Liuxingbingxue Zazhi, 2018. [43] M. Momin, F. Fan, J. Li, J. Jia, L. Zhang, Y. Zhang and Y. Huo, “ Joint effects of body mass index and waist circumference on the incidence of hypertension in a community-based Chinese population,” Obesity facts, vol. 2, no. 2, pp. 245-255, 2020. [44] G. Valentino, C. Hernández, R. Tagle, L. Orellana, M. Adasme, F. Baraona and M. Acevedo, “Urinary sodium‐to‐potassium ratio and body mass index in relation to high blood pressure in a national health survey in Chile.,” The Journal of Clinica, 2020. [45] B. Fan, Y. Yang, A. Dayimu, G. Zhou, Y. Liu, S. Li and F. Xue, “Body mass index trajectories during young adulthood and incident hypertension: a longitudinal cohort in Chinese population,” Journal of the American Heart Association, vol. 8, p. 8, 2019. [46] C. A. Schiavon, A. C. Bersch-Ferreira, E. V. Santucci, J. D. Oliveira, C. R. Torreglosa, P. T. Bueno and O. Berwanger, “Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension),” Circulation, vol. 137, no. 11, pp. 1132-1142, 2018. [47] A. L. Li, Q. Peng, Y. Q. Shao, X. Fang and Y. Y. Zhang, “The effect of body mass index and its interaction with family history on hypertension: a case–control study,” Clinical Hypertension, vol. 25, no. 1, pp. 1-8, 2019. [48] G. C. Linderman, J. Lu, Y. Lu, X. Sun, W. Xu, K. Nasir and H. M. Krumholz, “Association of body mass index with blood pressure among 1.7 million Chinese adults,” JAMA network open, vol. 4, no. e181271-e181271, p. 1, 2018. [49] N. T. T. Tran, C. L. Blizzard, K. N. Luong, N. L. V. Truong, B. Q. Tran, P. Otahal and M. Callisaya, “The importance of waist circumference and body mass index in cross-sectional relationships with risk of cardiovascular disease in Vietnam,” PloS one, vol. 5, no. e0198202, p. 13, 2018. [50] S. Ryu, E. Frith, Z. Pedisic, M. Kang and P. D. Loprinzi, “Secular trends in the association between obesity and hypertension among adults in the United States, 1999–2014,” European Journal of Internal Medicine, vol. 62, pp. 37-42, 2019. [51] M. Kuwabara, R. Kuwabara, K. Niwa, I. Hisatome, G. Smits, C. A. Roncal-Jimenez and D. I. Jalal, “Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects,” Nutrients, vol. 8, no. 1011, p. 10, 2018. [52] M. A. Khan, K. Mathur, G. Barraza, S. Sin, C. J. Yang, R. Arens and J. Mahgerefteh, “The relationship of hypertension with obesity and obstructive sleep apnea in adolescents,” Pediatric pulmonology, vol. 55, no. 4, pp. 1020-1027, 2020. [53] D. Nishigaki, R. Yamamoto, M. Shinzawa, Y. Kimura, Y. Fujii, K. Aoki and T. Moriyama, “Body mass index modifies the association between frequency of alcohol consumption and incidence of hypertension in men but not in women: a retrospective,” Hypertension Research, vol. 43, no. 4, pp. 322-330., 2020. [54] A. Jayedi and S. Shab-Bidar, “Nonlinear dose–response association between body mass index and risk of all-cause and cardiovascular mortality in patients with hypertension: A meta-analysis,” Obesity research & clinical practice, vol. 12, no. 1, pp. 16-28, 2018. [55] F. Khalid, A. Siddique, J. A. Siddiqui, G. Panhwar, S. Singh, A. Anwar and A. A. Hashmi, “Correlation Between Body Mass Index and Blood Pressure Levels Among Hypertensive Patients: A Gender-Based Comparison,” Cureus, vol. 12, no. 10, 2020. [56] S. H. Joo, S. H. Yun, D. W. Kang, C. T. Hahn, H. K. Lim and C. U. Lee, “Body mass index in mild cognitive impairment according to age, sex, cognitive intervention, and hypertension and risk of progression to Alzheimer's disease,” Frontiers in Psychiatry, vol. 142, p. 9, 2018. [57] K. Bai, X. Chen, Z. Shi, K. He, X. Hu, R. Song and S. Shi, “Hypertension modifies the associations of body mass index and waist circumference with all-cause mortality among older Chinese: a retrospective cohort study,” BMC geriatrics, vol. 22, no. 1, 2022. [58] C. Shen, Z. Zhou, S. Lai, X. Tao, D. Zhao, W. Dong and J. Gao, “Urban-rural-specific trend in prevalence of general and central obesity, and association with hypertension in Chinese adults, aged 18–65 years,” BMC Public Health, vol. 19, no. 1, pp. 1-8, 2019. [59] B. Sakboonyarat, R. Rangsin, A. Kantiwong and M. Mungthin, “Prevalence and associated factors of uncontrolled hypertension among hypertensive patients: a nation-wide survey in Thailand,” BMC Research Notes, vol. 12, no. 1, pp. 1-8, 2019. [60] X. Zhang, M. Zhang, C. Li, L. Wang, J. Wu, Z. Huang and L. Wang, “Associations Between Hypertension Status and Increased Heart Rate—China, 2015,” China CDC Weekly, vol. 771, no. 2, p. 40, 2020. [61] X. Liang, L. Xiao, Y. Luo and J. Xu, “Prevalence and risk factors of childhood hypertension from birth through childhood: a retrospective cohort study,” Journal of human hypertension, vol. 34, no. 2, pp. 151-164, 2020. [62] E. Ana, N. Chamidah, P. Andriani and B. Lestari, “Modeling of hypertension risk factors using local linear of additive nonparametric logistic regression,” Journal of Physics: Conference Series, vol. 1397, no. 1, p. 012067, 2019. [63] P. Panindre, V. Gandhi and S. Kumar, “Instantaneous Heart Rate-based Automated Monitoring of Hypertension using Machine Learning,” 2021 International Conference on Computing, Communication, and Intelligent Systems (ICCCIS), pp. 732-737, 2021. [64] M. Zhao, Y. Chen, M. Wang, C. Wang, S. Yao, Y. Li and H. Xue, “Relationship between resting heart rate and incident heart failure in patients with hypertension: The Kailuan Cohort Study in China,” The Journal of Clinical Hypertension, vol. 22, no. 12, 2020. [65] M. Esler, G. Lambert, D. Esler, C. I. Sari, L. Guo and G. Jennings, “Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension.,” Journal of Hypertension, vol. 38, no. 8, pp. 1488-1495, 2020. [66] X. Li, T. Kong, Y. Yao, J. Chen, K. Sun, S. Zhang and X. Fan, “Prevalence and factors associated with fast resting heart rate in hypertensive and normotensive patients,” Clinical and Experimental Hypertension, vol. 42, no. 1, pp. 8-15, 2020. [67] P. Palatini, F. Saladini, L. Mos, C. Fania, A. Mazzer and E. Casiglia, “Low night-time heart rate is longitudinally associated with lower augmentation index and central systolic blood pressure in hypertension,” European Journal of Applied Physiology, vol. 118, no. 3, pp. 543-550, 2018. [68] E. Kokhan, G. Kiyakbaev, E. Ozova, V. Romanova and Z. H. Kobalava, “Effect of beta-blocker-induced heart rate lowering on left atrial function in patients with hypertension and recurrent atrial fibrillation,” European Heart Journal, vol. 41, 2020. [69] A. Massaro, V. Maritati, N. Savino and A. Galiano, “Neural networks for automated smart health platforms oriented on heart predictive diagnostic big data systems,” 2018 AEIT International Annual Conference, no. IEEE, pp. 1-5, 2018. [70] G. Elia, A. Margherita, A. Massaro and A. Vacca, “Adoption of open innovation in the COVID-19 emergency: developing a process-based information coordination system,” Business Process Management Journal, vol. 28, no. 2, pp. 419-441, 2022. |
URI: | https://mpra.ub.uni-muenchen.de/id/eprint/113242 |